[Infection risks in multiple sclerosis therapy by infusion of disease modifying drugs]. Winkelmann A, Löbermann M, Reisinger E, Hartung H-P, Zettl UK Nervenarzt. 2015 Jul 19. PMID: 26187545. Abstract CommentRecommendBookmarkWatch